Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
Background: Monkeypox virus (mpox) disease is caused by a double-stranded DNA virus from the Poxviridae family. The mpox virus showed structural similarity with smallpox virus disease. The recent outbreak of mpox infection in the rest of African countries causes public health issues of increased pan...
Saved in:
Main Authors: | M.Valan Arasu (Author), P. Vijayaragavan (Author), Sumitha Purushothaman (Author), M.A. Rathi (Author), Naif Abdullah Al-Dhabi (Author), V.K. Gopalakrishnan (Author), Ki Choon Choi (Author), S. Ilavenil (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
by: Purushothaman Indu, et al.
Published: (2020) -
Antibacterial activity of peptides and bio-safety evaluation: in vitro and in vivo studies against bacterial and fungal pathogens
by: Mariadhas Valan Arasu, et al.
Published: (2023) -
Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections
by: Shine Kadaikunnan, et al.
Published: (2024) -
Mpox (Monkeypox) with atypical clinical presentation and distinctive dermoscopic findings
by: Wei-Yao Wang, et al.
Published: (2023) -
Phasing out monkeypox: mpox is the new name for an old disease
by: Clarissa R. Damaso
Published: (2023)